1-8 of 8
Armando López-Guillermo, MD PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase 2 Randomized Trial Comparing Standard RCHOP Versus Brcap (bortezomib, rituximab, cyclophosphamide, adriamycin and prednisone) As First Line Treatment in Young Patients with High-Risk Diffuse Large B-Cell Lymphoma (DLBCL). a Study from Spanish Group Geltamo

Eva González-Barca, MD PhD, Estrella Carrillo-Cruz, MD, Carlos Grande, MD PhD, Alejandro Martín, MD PhD, Mónica Coronado, MD, Santiago Montes-Moreno, MD, Santiago Mercadal, MD, Josep Maria Roncero, MD, Jaime Pérez de Oteyza, MD, Concepción Nicolás, MD, María José Rodríguez-Salazar, MD, Juan-Manuel Sancho, Luis Palomera, MD PhD, Javier López-Jiménez, MD, Carmen Albo, MD, Francisco-Javier Peñalver, MD, José Ángel Hernández, MD, Armando López-Guillermo, MD PhD, María José Ramírez, MD, Isidro Jarque, MD, Joan Bargay, MD, Miguel Canales, MD PhD, Eulogio Conde, MD PhD, Dolores Caballero, MD PhD
Journal: Blood
Blood (2016) 128 (22): 4201.
https://doi.org/10.1182/blood.V128.22.4201.4201
Published: 2016
Journal Articles

Recurrent Mutations Of NOTCH Genes In Follicular Lymphoma

Kennosuke Karube, Daniel Martinez, Cristina Royo, PhD, Paola Castillo, Alexandra Valera, Andreas Rosenwald, MD, German Ott, MD, Daniel Esteban, MD, Eva Gine, MD, PhD, Armando Lopez-Guillermo, MD, PhD, Elias Campo
Journal: Blood
Blood (2013) 122 (21): 4253.
https://doi.org/10.1182/blood.V122.21.4253.4253
Published: 2013
Journal Articles

Lymphomas With MYC -Translocation Other Than Burkitt’s Have An Aggressive Presentation and Poor Response To Immunochemotherapy: Study Of 34 Cases

Jose-Tomas Navarro, MD, PhD, Maria Joao Baptista, PhD, Alejandra Martinez-Trillos, MD, Gustavo Tapia, MD, Jose Angel Hernandez-Rivas, MD, PhD, Olga Garcia, Anna Muñoz-Marmol, PhD, Juan-Manuel Sancho, MD, PhD, Fuensanta Millá, MD, PhD, Evarist Feliu, MD, PhD, Jose-Luis Mate, MD, PhD, Armando Lopez-Guillermo, MD, PhD, Josep-Maria Ribera, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 5083.
https://doi.org/10.1182/blood.V122.21.5083.5083
Published: 2013
Journal Articles

Follicular Dendrytic Cells Deliver Angiogenesis Signaling To Follicular Lymphoma Cells That Is Hampered By The Pan-PI3K Inhibitor NVP-BKM120

Alba Matas-Céspedes, MS, Vanina Rodriguez, Susana Kalko, PhD, Eva Gine, MD, PhD, Elias Campo, MD, PhD, Gael Roue, PhD, Armando Lopez-Guillermo, MD, PhD, Dolors Colomer, PhD, Perez-Galan Patricia, PhD
Journal: Blood
Blood (2013) 122 (21): 3072.
https://doi.org/10.1182/blood.V122.21.3072.3072
Published: 2013
Journal Articles

Updated 6 Year Follow-Up Of The PRIMA Study Confirms The Benefit Of 2-Year Rituximab Maintenance In Follicular Lymphoma Patients Responding To Frontline Immunochemotherapy

Gilles Andre Salles, MD, PhD, John Francis Seymour, MBBS, FRACP, PhD, Pierre Feugier, MD, PhD, Fritz Offner, MD, Armando Lopez-Guillermo, MD, PhD, David Belada, M.D., Ph.D., Luc Xerri, MD, PhD, Reda Bouabdallah, MD, John Catalano, MBBS FRACP FRCPA, Brice Pauline, MD, Dolores Caballero, MD, PhD, Corinne Haioun, MD, PhD, Lars Moller Pedersen, Alain Delmer, MD, David Simpson, Sirpa Leppa, Pierre Soubeyran, Anton Hagenbeek, MD, PhD, Olivier Casasnovas, MD, Tanin Intragumtornchai, MD, Christophe Ferme, MD, Maria Gomes da Silva, Catherine Sebban, MD, Andrew Lister, Jane A Estell, MBBS, FRCPA, FRACP, Gustavo Milone, Anne Sonet, MD, Bertrand Coiffier, MD, PhD, Herve Tilly, MD
Journal: Blood
Blood (2013) 122 (21): 509.
https://doi.org/10.1182/blood.V122.21.509.509
Published: 2013
Journal Articles

A Randomized Phase II Study Comparing Consolidation With a Single Dose Of 90 y Ibritumomab Tiuxetan (Zevalin®) (Z) Vs. Maintenance With Rituximab (R) For Two Years In Patients With Newly Diagnosed Follicular Lymphoma (FL) Responding To R-CHOP. Preliminary Results At 36 Months From Randomization

Armando Lopez-Guillermo, MD, PhD, Miguel A. Canales, MD, PhD, Ivan Dlouhy, Javier Briones, MD, Dolores Caballero, MD, PhD, Juan Manuel Sancho, Sr., MD, Santiago Mercadal Vilchez, MD, Jose María Moraleda, MD, María José Terol, MD, PhD, Antonio Salar, MD, Luis Palomera, MD, Santiago Gardella, MD, Isidro Jarque, MD, Secundino Ferrer, Joan Bargay, MD, Andres Lopez, Carlos Panizo, Anna Muntanola, MD, Carlos Montalban, Eulogio Conde, MD, PhD, Miguel Hernandez, MD, Alfons Soler, Julian Marin, MD, Jose García Marco, Guillermo Deben, José Francisco Tomas, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 369.
https://doi.org/10.1182/blood.V122.21.369.369
Published: 2013
Journal Articles

Daratumumab, a Novel Human Anti-CD38 Monoclonal antibody shows Anti-Tumor Activity In Mouse Models Of MCL, FL and CLL

Alba Matas-Céspedes, MS, Anna Vidal Crespo, MS, Vanina Rodriguez, Gael Roue, PhD, Armando Lopez-Guillermo, MD, PhD, Elias Campo, MD, PhD, Dolors Colomer, PhD, Jeroen Lammerts van Bueren, PhD, Joost M Bakker, PhD, Adrian Wiestner, MD, PhD, Paul W.H.I. Parren, PhD, Patricia Perez-Galan, PhD
Journal: Blood
Blood (2013) 122 (21): 378.
https://doi.org/10.1182/blood.V122.21.378.378
Published: 2013
Journal Articles

Analysis of microRNA Patterns in Hodgkin’s Lymphoma (HL).

Alfons Navarro, PhD, Anna Gaya, MD, Aina Pons, PhD, Pau Abrisqueta, MD, Bernat Gel, PhD, Antonio Martinez, MD, PhD, Armando Lopez-Guillermo, MD, PhD, Carmen Martinez, MD, PhD, Miquel Granell, MD, Rosa Artells, PhD, Sonia Jansa, PhD, Alvaro Urbano-Ispizua, MD, PhD, Emili Montserrat, MD, PhD, Mariano Monzo, MD, PhD
Journal: Blood
Blood (2006) 108 (11): 474.
https://doi.org/10.1182/blood.V108.11.474.474
Published: 2006